Search clinical trials for: Amikacin

Total 80 results

University Hospital St Luc, Brussels
Université Catholique de Louvain; University of Applied Sciences of Western... and other collaborators

Completed

In Vitro Assessment of a Breath-synchronized Vibrating Mesh Nebulizer During Non Invasive Ventilation (Synchro-Neb)

Lung Diseases | Asthma | Cystic Fibrosis | COPD | Respiratory Diseases

Belgium
Groupe Hospitalier Pitie-Salpetriere

Completed

Nebulized Ceftazidime and Amikacin in Ventilator Associated Pneumonia

Pneumonia

France
Raja Isteri Pengiran Anak Saleha Hospital

Terminated

Raja Isteri Pengiran Anak Saleha Appendicitis Treatment Without Operation (RIPASA-TWO)

Surgery | Appendicitis

Brunei Darussalam
Cliniques universitaires Saint-Luc- Université...

Unknown

Evaluation of Nebulization and Positive Expiratory Pressure Combination

Cystic Fibrosis | Healthy Subjects

Belgium
Thammasat University

Completed

Effect of Additional Nebulized Amikacin in Ventilator-Associated Pneumonia Caused by Gram Negative Bacteria

Pneumonia, Ventilator-Associated

Thailand
Shanghai Pulmonary Hospital, Shanghai, China

Unknown

Therapy of Bronchoalveolar Lavage and Local Amikacin Injection in Patients With Acute Exacerbation of Bronchiectasis

Bronchiectasis

China
Cliniques universitaires Saint-Luc- Université...

Unknown

Which Apparatus for Inhaled Pentamidine?

Healthy

Belgium
University Medical Center Groningen

Recruiting

Pharmacokinetic Evaluation and Local Tolerability of Dry Powder Amikacin Via the Cyclops™

Tuberculosis

Netherlands
National Heart Institute, Egypt

Completed

Nebulized Amikacin Versus Intravenous Amikacin in the Treatment of Nosocomial Pneumonia

Pneumonia
Association Pour La Promotion A Tours De La Reanimation...

Unknown

Pharmacokinetics of Nebulized Amikacin in Patients With Pneumonia Undergoing Mechanical Ventilation (DARTAGNAN)

Ventilator Associated Pneumonia

France
Cardeas Pharma

Completed

Open-Label Phase 1 Study of Aerosolized Amikacin and Fosfomycin in Healthy Volunteers

Healthy

United States
Insmed Incorporated

Withdrawn

Study to Evaluate Arikace™ in CF Patients With Chronic Infection Due to Pseudomonas Aeruginosa

Cystic Fibrosis
Insmed Incorporated

Completed

A Study to Investigate Lung Deposition of Inhaled Amikacin-loaded Liposomes in Healthy Male Participants

Healthy Volunteers
Assistance Publique - Hôpitaux de Paris

Completed

Impact of Imipenem With Amikacin Pharmacokinetic and Pharmacodynamic (IMPACT)

Ventilator Associated Pneumonia

France
Insmed Incorporated
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria

Mycobacterium Infections, Nontuberculous

United States, Canada
Pontificia Universidad Catolica de Chile

Completed

Population Pharmacokinetics of Amikacin in Neonates

Neonatal Sepsis, Late-Onset

Chile
Centre Hospitalier Universitaire de Nīmes

Completed

Personalized Dose Optimization of Amikacin Guided by Pharmacokinetic Modeling Software in Patients With Septic Shock (AMINO BESTDOSE)

Shock, Septic

France
Assistance Publique Hopitaux De Marseille

Unknown

Amikacin Pharmacokinetic Profile in Plasma and Tissue After an Administration Using Impregnated Dressings in Burned Patient Population (AMIKACINE)

Burn Patients

France
Insmed Incorporated

Completed

Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone (CONVERT)

Mycobacterium Infections, Nontuberculous
Insmed Incorporated

Completed

Extension Study of Liposomal Amikacin for Inhalation in Cystic Fibrosis (CF) Patients With Chronic Pseudomonas Aeruginosa (Pa) Infection

Cystic Fibrosis

France, Poland, United Kingdom, Germany, Spain, Belgium, Bulgaria, Serbia, Denmark, Greece, Netherlands, Hungary, Ireland, Slovakia, Canada, Italy, Austria
Bayer
Nektar Therapeutics

Completed

A Study to Determine the Correct Dose of Amikacin Which is Delivered Directly to the Lungs of Ventilated Patients as an Aerosol Via an Investigational Device Called the Pulmonary Delivery Device System (PDDS)

Pneumonia

France, Spain, United States
Polyphor Ltd.

Completed

DDI Study to Investigate Interaction Between Amikacin and POL7080

Healthy

Germany
Cardeas Pharma

Withdrawn

Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative and / or Gram-positive Bacterial Colonization

Pneumonia, Bacterial
University Hospital, Basel, Switzerland

Completed

Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological Disorder

Febrile Neutropenia (FN)

Switzerland
Insmed Incorporated

Completed

Single Dose Escalation Study of TR02 (Sustained Lipid Inhalation Technology [SLIT™] Amikacin) in Participants With Cystic Fibrosis (CF) Having Chronic Infections of Pseudomonas Aeruginosa

Cystic Fibrosis
Cliniques universitaires Saint-Luc- Université...

Completed

Evaluation of the Timing of the Nebulization Related to the Physiotherapy Session

Cystic Fibrosis

Belgium
University Hospital, Tours

Completed

Study Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumonia (AMIKINHAL)

Pneumonia, Ventilator-Associated

France
Insmed Incorporated

Completed

Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) - Extension Phase

Cystic Fibrosis

Poland, Ukraine, Serbia, Belgium, Hungary, Slovakia, North Macedonia
Rambam Health Care Campus

Withdrawn

Amikacin Penetration Into the Cerebrospinal Fluid

Gram Negative Meningitis | Post Traumatic Bacterial Meningitis

Israel
Cardeas Pharma

Completed

Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia (IASIS)

Pneumonia, Bacterial

Spain, United States, Greece, Hungary, Turkey, Puerto Rico, France
Khon Kaen University
National Research Council of Thailand

Completed

Once-Daily Amikacin Plus Cloxacillin in Febrile Neutropenic Children

Cancer | Neutropenia | Fever
Insmed Incorporated

Completed

Multidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKACE™)

Cystic Fibrosis

Poland, Ukraine, Serbia, Belgium, Hungary, Slovakia, North Macedonia
Bayer
Nektar Therapeutics

Completed

Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-ventilated Patients With Nosocomial Pneumonia

Pneumonia

United States, France
Bayer
Nektar Therapeutics

Completed

Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia (INHALE 1)

Pneumonia, Bacterial

Korea, Republic of, Taiwan, United States, Canada, Philippines, Turkey, Thailand, Australia, Mexico, Colombia, Czechia, Brazil
Shanghai Zhongshan Hospital
Ruijin Hospital; The First Affiliated Hospital of Guangzhou Medical University

Completed

Prevention of Acute Exacerbation in Subjects With COPD by Bacterial Decolonization in Lower Respiratory Tract (PAEAN)

Chronic Obstructive Pulmonary Disease (COPD)

China
Insmed Incorporated

Completed

Open-label Safety Extension Study Assessing Safety and Tolerability of LAI in Patients Who Participated in Study INS-212

NTM Lung Infection Due to MAC
Shanghai Zhongshan Hospital

Not yet recruiting

Inhaled Amikacin in Preventing AECOPD

COPD | COPD Exacerbation

China
Samsung Medical Center

Withdrawn

Inhaled Amikacin Treatment for Nontuberculous Mycobacterial Lung Disease

Pulmonary Non-tuberculous Mycobacterial Lung Disease

Korea, Republic of
Medical University of Vienna

Recruiting

PRF With Topical Antibiotics or Antiseptics in Chronical Wounds Version 1.4 (PRF-TAT)

Chronic Skin Ulcer

Austria
Hospices Civils de Lyon

Recruiting

Observed Pharmacokinetic of Piperacillin/Tazobactam Compared to Amikacin in ICU (OPTIMA)

Sepsis | Septic Shock | Sepsis Syndrome

France
Universitaire Ziekenhuizen KU Leuven

Completed

Pharmacokinetic/Pharmacodynamic Evaluation Amikacin in Critically Ill Patients Admitted at the Emergency Department

Sepsis
Qilu Hospital of Shandong University

Completed

Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis

Non-Cystic Fibrosis Bronchiectasis

China
Sanofi

Completed

A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation (ATHENA)

Atrial Fibrillation | Atrial Flutter

United States, Canada, Poland, Russian Federation, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Turkey, India, Malaysia, Philippines, Singapore, Taiwan, Belgium, Czech Republic, Mexico, Tunisia, Argentina, Finland, Hungary, I... and more
Antonios Likourezos

Recruiting

Single Dose Amikacin for Uncomplicated Cystitis in the ED: A Feasibility Study

Urinary Tract Infections

United States
University of Sarajevo
KU Leuven; Amsterdam UMC, location VUmc; Leiden University Medical Center; University...

Recruiting

Amikacin Pharmacokinetics to Optimize Dosing Recommendations in Neonates With Perinatal Asphyxia Treated With Hypothermia (Amicool)

Asphyxia Neonatorum

Bosnia and Herzegovina
Insmed Incorporated

Completed

Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex (ARISE)

Mycobacterium Infections, Nontuberculous

United States, Argentina, Australia, Austria, Canada, Chile, Denmark, Germany, Israel, Italy, Korea, Republic of, New Zealand, Spain, Taiwan
Pfizer

Completed

A Comparative Phase IV Study Evaluating Efficacy & Safety Of Magnex(Cefoperazone-Sulbactam) In Intraabdominal Infections

Infection

India
Rabin Medical Center

Unknown

Fixed-dose Amikacin for Elderly UTI

Urinary Tract Infections | Elderly Infection
Leiden University Medical Center

Recruiting

Patient Satisfaction and Long-term Safety of Intravesical Aminoglycoside Instillations in UTI Prevention (INSTILMENT)

Urinary Tract Infections | Recurrent Urinary Tract Infection

Netherlands
Insmed Incorporated

Completed

Safety and Tolerability Study of 2 Dose Level of Arikayce™ in Patients With Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa.

Bronchiectasis

United States, United Kingdom, Bulgaria, India, Serbia, Ukraine, Greece, Hungary, Poland

Search clinical trials for: Amikacin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations